In a systematic review of clinical traumatic brain injury studies, Cerebrolysin was among therapies showing improved functional outcomes and possible neuroprotective properties.
In plain wordsA review of clinical brain injury studies found improved functional outcomes and possible neuroprotective properties with Cerebrolysin.
- Peptide
- Cerebrolysin
- Outcome
- IncreaseFunctional outcomes
- Study
n: not reported in source
- Outcome group
- Exercise and physical function · Nervous system and cognition
- Studied dose
- Dose not stated
Source sentences
Eight of these therapies demonstrated possible neuroprotective properties and improved functional outcomes, of which five were investigated with randomized clinical trials: statins, N-acetyl cysteine (NAC), Enzogenol, Cerebrolysin, and nitric oxide synthase inhibitor (VAS203).
3 context sentences(design, population, supporting numbers)
The purpose of this systematic review was to evaluate the recent clinical studies from January 2013 through November 2015 that investigated neuroprotective functional outcomes of pharmacological agents after TBI.
This systematic review included only full-length clinical studies and case series that included at least five patients and were published in the English language.
Only studies that examined functional clinical outcomes were included.